MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy
3Phase III in Spain, 2Phase II, 1Phase I